Treasure Island (603567.SH) subsidiary obtains registration certificate for moxifloxacin hydrochloride tablets.

China Fortune Financial App News, Treasure Island (603567.SH) announced that recently, its wholly-owned subsidiary Harbin Treasure Pharmaceutical Co., Ltd. received the official approval and issuance of the Drug Registration Certificate for the hydrochloride of levofloxacin tablets by the National Medical Products Administration. This drug is used to treat acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, uncomplicated skin and skin tissue infections, complicated skin and skin tissue infections, complicated intra-abdominal infections, plague, and mild to moderate pelvic inflammatory diseases without tubal-ovarian abscess.